To include your compound in the COVID-19 Resource Center, submit it here.

Titan's Probuphine meets Phase III endpoint

Titan Pharmaceuticals Inc. (OTCBB:TTNP) said Probuphine buprenorphine met the primary endpoint in a

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE